Safety, pharmacodynamics, and pharmacokinetics of BAY 59–7939—an oral, direct factor Xa inhibitor—after multiple dosing in healthy male subjects - Kubitza,D.; Becka,M.; Wensing,G.; Voith,B.; Zuehlsdorf,M. (Eur J Clin Pharmacol, 2005)